Affiliation:
1. the Program in Pharmaceutical Outcomes and Policy Research, College of Pharmacy (T.N.T., J.W.M.), the Department of Neurology (P.H.D.), the Department of Preventive Medicine and Environmental Health (J.C.T.), and the Department of Social Work (J.H., M.F.J.), University of Iowa (Iowa City).
Abstract
Background and Purpose
Stroke imposes a substantial economic burden on individuals and society. This study estimates the lifetime direct and indirect costs associated with the three major types of stroke: subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (ISC).
Methods
We developed a model of the lifetime cost of incident strokes occurring in 1990. An epidemiological model of stroke incidence, survival, and recurrence was developed based on a review of the literature. Data on direct cost of treating stroke were obtained from Medicare claims data, the 1987 National Medical Expenditure Survey (NMES), and insurance claims data representing a group of large, self-insured employers. Indirect costs (the value of foregone market and nonmarket production) associated with premature morbidity and mortality were estimated based on data from the US Bureau of Economic Analysis and the 1987 NMES.
Results
The lifetime cost per person of first strokes occurring in 1990 is estimated to be $228 030 for SAH, $123 565 for ICH, $90 981 for ISC, and $103 576 averaged across all stroke subtypes. Indirect costs accounted for 58.0% of lifetime costs. Aggregate lifetime cost associated with an estimated 392 344 first strokes in 1990 was $40.6 billion: $5.6 billion for SAH, $6.0 billion for ICH, and $29.0 billion for ISC. Acute-care costs incurred in the 2 years following a first stroke accounted for 45.0%, long-term ambulatory care accounted for 35.0%, and nursing home costs accounted for 17.5% of aggregate lifetime costs of stroke.
Conclusions
The lifetime cost of stroke varies considerably by type of stroke and entails considerable costs beyond the first 2 years after a stroke.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)
Reference55 articles.
1. Asplund K Marke LA Terent A Gustafsson C Wester PO. Costs and gains in stroke prevention: European perspective. Cerebrovasc Dis . 1993;3(suppl 1):34-42.
2. Drummond M Ward G. The financial burden of stroke and the economic evaluation of treatment alternatives. In: Rose FC ed. Stroke: Epidemiological Therapeutic and Socioeconomic Aspects . London UK: Royal Society of Medicine Services Ltd; 1986.
Cited by
676 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献